Primex Pharmaceuticals appoints Dan Spacie as Global Commercial Head
Zug, 24th September 2019, Swiss pharmaceutical company Primex Pharmaceuticals AG announces the appointment of Mr. Dan Spacie, as Global Commercial Head to the Executive Management Team led by CEO Alan Knox.Dan Spacie has joined Primex Pharmaceuticals from Syneos Health, where he was President, Commercial, Europe. Syneos Health is a fully integrated biopharmaceutical solutions organization, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO). Prior to Syneos, Mr. Spacie held several leadership roles including Managing Director at STADA UK affiliates